Virtual screening methods fall broadly into two categories: ligand- and structure-based. Ligand-based virtual screening doesn’t require a target protein structure, Instead, it leverages known active ...
State-of-the-art AI programs can support the development of drugs by predicting how proteins interact with small molecules.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback